The University of Maine

DigitalCommons@UMaine
Honors College
5-2012

Endoscopic Evaluation of the Response to Intrauterine Irrigation
with 3.3% N-Acetylcysteine in Mares
Christine T. Kissinger

Follow this and additional works at: https://digitalcommons.library.umaine.edu/honors
Part of the Large or Food Animal and Equine Medicine Commons

Recommended Citation
Kissinger, Christine T., "Endoscopic Evaluation of the Response to Intrauterine Irrigation with 3.3% NAcetylcysteine in Mares" (2012). Honors College. 61.
https://digitalcommons.library.umaine.edu/honors/61

This Honors Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted
for inclusion in Honors College by an authorized administrator of DigitalCommons@UMaine. For more information,
please contact um.library.technical.services@maine.edu.

ENDOSCOPIC EVALUATION OF THE RESPONSE TO INTRAUTERINE
IRRIGATION WITH 3.3% N-ACETYLCYSTEINE IN MARES
by
Christine T. Kissinger

A Thesis Submitted in Partial Fulfillment
of the Requirements for a Degree with Honors
(Animal and Veterinary Sciences)

The Honors College
University of Maine
May 2012

Advisory Committee:
Robert Causey, Assoc. Professor of Animal and Vet. Sciences, Advisor
François Amar, Assoc. Professor and Chair of Chemistry, Honors College
Timothy Bowden, Asst. Professor of Aquaculture
Edith Pratt Elwood, Adjunct Asst. Professor of Sociology, Honors College
Rita Seger, M.D., Ph.D.

© 2012 Christine T. Kissinger
All Rights Reserved

Abstract
Strangles is a contagious disease caused by the bacteria Streptococcus equi that
has continued to affect horses through the development of long-term asymptomatic
carriers. Effective identification of horses carrying S. equi and treatment of these horses
has proven difficult. The chemical N-acetylcysteine (NAC) has mucolytic properties and
has been used in the treatment of carriers; however the reports show controversial and
anecdotal evidence regarding the effectiveness and inflammatory side effects. The goal
of this study is to observe whether NAC is irritating to mucosal tissue with the interest of
determining if NAC could be used to treat the carrier state of Strangles. Ten, healthy
Standardbred mares were used in this random study which involved the endoscopic
evaluation of uterine tissue in response to one of three treatment groups; no infusion,
Lactated Ringer’s Solution (LRS), or a 3.3% NAC solution. The collected endoscopic
images were subjectively evaluated for signs of tissue irritation by a double-blinded
researcher. The results from this study indicate that the uterine tissues showed minor
inflammation for the treatment groups of LRS and NAC when compared to the no
infusion group, and NAC showed fewer signs of inflammation when compared to LRS.
These results indicate that NAC may have anti-inflammatory properties.
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1. Strangles Disease
Strangles is an upper respiratory disease of equid species that is caused by the
bacterium Streptococcus equi. Strangles is an economically significant disease due to the
extensive welfare costs and quarantine protocols that result as a consequence of this
infection. The S. equi bacteria can be transmitted to other horses by direct contact or
indirectly through fomite and environmental contamination. Strangles therefore is a very
contagious disease with an infection rate of 85-100% for horses that come in contact with
S. equi bacteria (Taylor and Wilson, 2006). Upon coming in contact with this organism,
there is a 3-8 day incubation period before clinical signs develop (Taylor and Wilson,
2006). Clinical signs of strangles include a fever greater than 103 F, swelling and
abscess formation of lymph nodes, mucopurulent nasal discharge, and local inflammation
and edema. These signs can persist for 3-4 weeks and bacteria can be shed for an
additional 4 week period after clinical signs dissipate (Taylor and Wilson, 2006; Sweeney
et al., 2005).

There are many complications of strangles that can raise the mortality rate from
the average of 8-10 percent (Holland et al., 2006; Sweeney et al., 2005; Newton et al.,
1997) to nearly 40 percent (Sweeney et al., 2005). Approximately 20% of horses can
have complications from strangles (Sweeney et al., 2005). Two major complications
include; “bastard strangles” - the systemic abscessation of lymph tissues, and purpura
haemorrhagica - an immune initiated hypersensitivity resulting in vasculitis.
Additionally, another 10% of infected horses, and in some outbreaks this is much higher
(Knowles et al., 2010; Newton et al., 2000), will become asymptomatic carriers of S. equi
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for extended periods of time (Waller et al., 2011; Rosser et al., 2007; Taylor and Wilson,
2006; Sweeney et al., 2005).

Streptococcus equi has several virulent factors that shield the bacteria from the
immune system and prevent phagocytosis and opsonization of the bacteria. The immune
system responds to the presence of S. equi by concentrating neutrophils in the lymph
tissues. This accumulation leads to the swelling of lymph nodes and can lead to abscess
formation. The guttural pouch carrier state is established when the retropharyngeal
lymph nodes abscess and drain into the guttural pouch (Waller et al., 2011). Once in the
guttural pouch, S. equi and mucus can solidify into masses called chondroids and be
present months later. A study by Newton et al. (1997) found that 5 out of 6 carriers of
strangles harbored S. equi bacteria in the guttural pouch for 7 to 34 months, allowing
undetected carriers to intermittently shed S. equi after the initial infection (Newton et al.,
2000). Streptococcus equi has a short life span outside of the horse, and it is this
prolonged carrier state that has allowed for this disease to be maintained within the equid
population (Waller et al., 2011).

A horse who is displaying clinical signs of strangles should be immediately
isolated from the rest of the barn and other horses should be closely monitored for signs
of infection. A veterinarian should confirm the diagnosis using a PCR test, bacterial
culture, or ELISA blood test. Strangles treatment options range from letting the horse
naturally fight the disease, to providing supportive care or antimicrobials based on the
severity of the symptoms. The most commonly used antibiotic for horses with strangles
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is penicillin. A positive S. equi horse should remain in isolation, following strict
biosecurity protocols, until all clinical signs have subsided and the horse is verified as
strangles free. Biosecurity measures include halting the movement of animals onto or off
of the farm, preventing cross contamination between the isolation area and the rest of the
farm, following strict hygiene measures for caretakers, and properly cleaning and
sanitizing the facilities and equipment. A complete biosecurity protocol can be
referenced from Holland et al. (2006), Taylor and Wilson (2006), or Sweeney et al.
(2005). Horses are typically deemed S. equi free after three consecutive negative
cultures, taken at least one week apart, and a negative PCR test. The PCR tests are used
in conjunction with cultures due to their higher sensitivity when compared to
nasopharyngeal swab cultures or guttural pouch lavage cultures, but also because PCR
tests cannot differentiate between live and dead bacteria due to their assessment of DNA
(Newton et al., 1997; 2000).

Holland and many others also recommend that the guttural pouches of infected
horses be cleaned out, treated, and confirmed negative for S. equi before an animal is
reintegrated into the herd (Holland et al., 2006; Taylor and Wilson, 2006; Sweeney et al.,
2005). The guttural pouches are two blind, air-filled sacs off of the auditory tube in the
head of a horse. Each sac has a volume of 300-500 milliliters (Baptiste et al., 2000;
Chiesa et al., 1999) and is believed to facilitate temperature regulation of brain blood
flow during extensive exercise as shown by Baptiste et al. (2000). It is important to
confirm that the guttural pouches are S. equi negative to help prevent the carrier state and
thus reduce the future incidence rate of strangles. There is also a need for the production
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of safe and effective vaccines to help prevent strangles infections. Although several
vaccines are available, safety concerns due to adverse reactions and partial protectiveness
have limited vaccine use to only at-risk horses (Waller and Jolley, 2007). A new vaccine
recently tested by Guss et al. (2009) holds promise for providing effective protection
against strangles. The 7-component vaccine includes two IgG endopeptidase antigens
and provides 85% protection when challenged with S. equi (Guss et al., 2009).

2. N-acetylcysteine
N-acetylcysteine (NAC) is a drug with multiple purposes; it is a mucolytic agent,
an anti-oxidant, a free radical scavenger, and can bind metals into complexes (Reinero et
al., 2011; Atkuri et al., 2007; Thorne Research Inc., 2002). Routes of administration for
NAC include oral, intravenously, or as an aerosol (Atkuri et al., 2007) with side effects
ranging from nausea and vomiting, to bronchospasm, and to anaphylactic shock (Levine
and LoVecchio, 2011; Henke and Ratjen, 2007). According to the package insert for
acetylcysteine 20% solution, using this chemical as an aerosol will result in mucolytic
responses which may be helpful in the treatment of the carrier state of strangles
(American Regent Inc., 2005).

N-acetylcysteine is primarily used in the medical industry to treat acetaminophen
overdoses. Acetaminophen is the pain and fever reducing chemical found in Tylenol,
Percocet, and Vicodin (Levine and LoVecchio, 2011). Acetaminophen is metabolized by
the liver into N-acetyl-p-benzoquinoneimine – a toxic compound that is usually
neutralized by glutathione. Glutathione is a compound that maintains oxidative-reductive
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balance in the body (Atkuri et al., 2007). Overdosing with acetaminophen leads to a
deficiency of glutathione, which causes N-acetyl-p-benzoquinoneimine accumulation in
the liver resulting in hepatotoxicity (Levine and LoVecchio, 2011). Acetaminophen
overdoses are treated with a 5% oral NAC solution and acts to prevent hepatotoxicity
through replenishing glutathione levels, or more directly through supplying cysteines the precursor to glutathione (Atkuri et al., 2007; American Regent Inc., 2005). Treatment
with NAC is most effective within 8 hours of overdose (Levine and LoVecchio, 2011;
Thorne Research Inc., 2002).

Another medical use of NAC utilizes the mucolytic properties of this chemical as
therapeutic treatment for patients with cystic fibrosis. Cystic fibrosis is a condition
caused by the malfunction of the chloride ion transporter resulting in dehydrated
respiratory secretions and mucus accumulation (Henke and Ratjen, 2007). Patients with
cystic fibrosis receive NAC in an aerosol form to thin respiratory mucus. Mucus contains
a disulfide bond, which is broken by the thiol group of NAC causing a reduction in
viscosity of respiratory mucus (Reinero et al., 2011; Henke and Ratjen, 2007; Thorne
Research, 2002). Although NAC has been proven to effectively breakdown mucus and
has been shown to reduce inflammation in the lungs of patients with cystic fibrosis
(Atkuri et al., 2007), it is no longer recommended for use because thinner mucus is more
difficult to expel from airways and there is also concern about the risk of exposing a
patient to bacteria that may be trapped in the mucus (Henke and Ratjen, 2007).
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In the veterinary field, NAC is used to treat acetaminophen overdoses in cats and
has been tested for other uses as well. A recent experiment by Reinero et al. (2011) has
assessed the safety of using NAC as a relief for asthmatic cats. Asthma is characterized
by increased airway inflammation and mucus secretion (Reinero et al., 2011). The cats
were sedated, given 400 mg of a 10% NAC solution and monitored for airway resistance
by a ventilator. Reinero et al. (2011) found that administration of NAC increased airway
resistance.

Additionally, NAC has been tested in the uterus of the horse as a treatment for
reducing post-breeding endometritus. Many mares suffer low fertility as a result from
post-breeding inflammation of the uterine lining and delayed uterine clearance (Melkus et
al., 2011). A previous University of Maine Honors College student measured
inflammatory responses of the uterus to the treatment of NAC or saline using cytology
and biopsy methods (McGhie - unpublished). Although these results were inconclusive,
a more recent study by Melkus et al. (2011), which also measured inflammatory
responses with cytology and biopsy procedures, has shown NAC to be beneficial.
Melkus et al. (2011) irrigated the uteri of horses with either a 5% NAC solution or saline
and evaluated for inflammatory responses at either 24 or 72 hours after irrigation. This
study found that irrigations of 5% NAC did not cause negative epithelial tissue effects in
the uterus and was anti-inflammatory when compared to tissue responses from saline
treatment (Melkus et al., 2011).
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In equine medicine, the use of NAC has been reported in the treatment of guttural
pouch diseases that result in empyema - the accumulation of pus (Sweeney et al., 2005;
Perkins et al., 2003; Carmalt, 2002). Strangles is one of the diseases where the use of
NAC has been noted. It is controversial whether there are additional benefits to including
NAC into a guttural pouch lavage solution, or if the physical flushing provides the
greatest benefit (Perkins et al., 2003). Perkins et al. (2003) discourages the use of NAC
in the guttural pouches due to “harmful and serious adverse effects.” Conversely, Bentz
et al. (1996) successfully treated a S. equi infected horse using NAC without negative
side effects. In this case study, the right guttural pouch was filled with thick purulent
fluid which responded well to saline lavages. The left guttural pouch however contained
a chondroid and did not dissolve after five saline lavages. In an attempt to avoid surgery,
a lavage of 20% NAC was used to dissolve the chondroid. After four lavages of 20%
NAC, the chondroid was completely dissolved as verified by endoscopy. The horse
involved in the case study by Bentz et al. (1996) experienced no negative side effects
from NAC. The common side effects noted by other authors in association with the
administration of NAC in horses are dysphagia- difficulty swallowing, and erythemaredness and inflammation (Sweeney et al., 2005; Perkins et al., 2003).

3. Objective
In this study, endoscopy will be used to visually describe and compare tissue
responses between three treatment groups; no infusion, 3.3% NAC solution, and Lactated
Ringer’s Solution (LRS). Due to the possibility of negative side effects and the
physiology of the guttural pouch, the uterus will be used as the site of irrigation. The
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epithelial tissue of the guttural pouch is similar to that of the uterus – both are mucosal
tissues composed of columnar ciliated cells intermixed with mucus secreting goblet cells
(Aughey and Frye, 2001; Causey et al., 2000). The major difference is that the guttural
pouch is a pseudo-stratified tissue, while the uterus is a single layer (Perkins et al., 2003;
Aughey and Frye, 2001). One of the keys to reducing strangles disease is treating the
carrier state, and NAC has the potential to effectively cleanse the guttural pouch of S.
Equi after strangles infections due to its mucolytic properties. This study will use an
endoscope to look for negative side effects of using a diluted NAC solution in the uterus.
Several other studies have assessed the inflammatory response of uterine tissues to NAC
using cytology and biopsy methods (Melkus et al., 2011; McGhie – unpublished);
however, these studies have not employed the use of an endoscope for visual assessment.

4. Materials and Methods
4.1 Randomization of Horses
Ten Standardbred mares from the J. F. Witter Teaching and Research Center were
randomly assigned to three treatment groups; no infusion (4), LRS (3), and NAC (3).
These horses were first ordered alphabetically and then given a random, three digit
number generated by an online database (www.random.org). The horses were then reordered numerically and systematically assigned to the treatment group. The table used
for this randomization process has been duplicated on the next page – in which columns
one and four were filled first, followed by column two and column three (see Table 1).
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Table 1: Process of Randomization
Randomly
*Name –
Treatment Group
Assigned #
by Number
281
Whiteout
No infusion
229
Ford
LRS
898
Annie
NAC
528
Andy
No infusion
119
Dewey
LRS
942
Honor
NAC
665
Jill
No infusion
755
Wicky
LRS
111
Blisstex
NAC
834
Holly
No infusion
*This column was filled in last.
**Upon arrival of Annie, her name was changed to Laney; Laney will be used for the rest
of this paper.
Names Alphabetical
Andy
**Annie
Blisstex
Dewey
Ford
Holly
Honor
Jill
Whiteout
Wicky

4.2 Preparation of Infusions
The infusions were prepared within four hours prior to irrigation. The LRS
infusions contained 180 mL of Lactated Ringer’s Solution (Hospira Inc.; each 100 mL
contains 600 mg sodium chloride, 310 mg sodium lactate-anhydrous, 30 mg potassium
chloride and 20 mg calcium chloride-dihydrate). The NAC infusions were made using
150 mL LRS and 30 mL of 20% Acetylcysteine (American Regents Inc.) to make a 3.3%
NAC solution. These solutions were measured and stored in 250 mL LRS bags for easier
transport to the barn.

4.3 Irrigation Procedure
Prior to irrigation, each horse was trans-rectally palpated and the uterus was
viewed by ultrasound. This was done to ensure that the uterus did not have any preexisting fluid accumulation as well as to determine the stage in the heat cycle. Horses
that displayed anxious behaviors in the stocks were mildly sedated with 5 or 10 mg of
9

detomidine hydrochloride (Dormosedan, Pfizer). The tail of the horse was wrapped using
a non-sterile palpation sleeve and bandage tape, and tied around the neck to give clear
access to the vulva. The vulva was then repeatedly washed using cotton soaked in warm
water and an iodine scrub (Prepodyne Scrub, West Agro). An insemination pipette was
then vaginally inserted through the cervix to the uterus using a sterile palpation sleeve
and non-spermicidal sterile lube (Priority Care). The uterus was then irrigated with either
LRS or NAC depending on the assigned treatment group. Horses in the no infusion
treatment group only underwent the endoscopy procedure detailed below.

4.4 Endoscopy Procedure
The endoscopy procedure was performed on all horses from the no infusion
treatment group and on all horses in the LRS and NAC groups 48 hours after irrigation.
Prior to endoscopy, the tail of each horse was wrapped and the vulva was washed as
described in section 4.3. Horses that displayed anxious behaviors were mildly sedated
with 5 or 10 mg of detomidine hydrochloride (Dormosedan, Pfizer). A 9mm diameter
flexible endoscope (Fujinon 4400) was then inserted into the uterus through the vagina
and cervix. A sterile palpation sleeve and non-spermicidal sterile lube (Priority Care)
were used for this process. A video and several still frame images of the uterus were
collected for each horse.

5. Results
The still frame endoscopic images collected during this study were reviewed and
subjectively scored for the presence (given a score of one) or absence (score of zero) of
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several traits that are indicative of inflammation. The traits assessed included;
hyperemia, edema, patchy inflammation, petechial hemorrhage, exudate, and transudate.
The scoring was completed by a researcher blinded to both the treatment group and
image origin. After scoring, a cumulative score was summed and the treatment group
and horse name were revealed. The image scores for each horse are recorded in Table 2
and correlated to the treatment group in Table 3. One of the assessed images from each
horse follows to support the score given to each uterus (Figures 1-10).

Horses 1, 2, 3 and 10 belonged to the no infusion treatment group and had
cumulative scores of zero, zero, one, and zero respectively. Horses 4, 7 and 9 belonged
to the NAC treatment group and had scores of two, one, and one respectively. All of
these uteri exhibited signs of hyperemia, and the uterus of Horse 4 had several areas with
increased redness – classified as patchy inflammation. Horses 5, 6 and 8 were infused
with LRS and had uterine scores of three, two, and two respectively. All of these uteri
also exhibited signs of hyperemia. Additionally, higher degrees of irritation were noted
for the horses that received the LRS infusion. The inflammatory signs noted included:
two uteri with edema, one with petechial hemorrhage, and one with transudate. These
results indicate that irrigation of either NAC or LRS will cause increased tissue irritation
and inflammation when compared to horses in the no infusion group. Additionally,
horses in the LRS group demonstrated greater degrees of inflammation in comparison to
the horses from the NAC group.
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Table 2: Subjective Evaluation of Endoscopic Images of the Uterus
Uterus Trait
Hyperemia
Edema
Patchy Inflammation
Petechial Hemorrhage
Exudate
Transudate
Total

#1
0
0
0
0
0
0
0

#2
0
0
0
0
0
0
0
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No
No
*Group Condition Infusion Infusion
*Horse Name Holly Whiteout

#3
1
0
0
0
0
0
1
No
Infusion
Andy

#4
1
0
1
0
0
0
2

NAC
Honor

#5
1
1
0
1
0
0
3

LRS
Dewey

#6
1
0
0
0
0
1
2

LRS
Wicky

#7
1
0
0
0
0
0
1

NAC
Laney

#8
1
1
0
0
0
0
2

LRS
Ford

Zero indicates absence of trait.
One indicates the presence of a trait.
*The information in these rows was not made available until after all images were scored.

#9
1
0
0
0
0
0
1

#10
0
0
0
0
0
0
0

No
NAC Infusion
Blisstex
Jill

13

Figure 1 - Horse #1 (above): Holly – score of zero.
Figure 2 - Horse #2 (below): Whiteout – score of zero.
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Figure 3 - Horse #3 (above): Andy – score of one; hyperemia.
Figure 4 - Horse #4 (below): Honor – score of two; hyperemia & patchy inflammation.

15

Figure 5 - Horse #5 (above): Dewey – score of 3; hyperemia, edema & petechial
hemorrhage.
Figure 6 - Horse #6 (below): Wicky – score of 2; hyperemia & transudate.

16

Figure 7 - Horse #7 (above): Laney – score of one; hyperemia.
Figure 8 - Horse #8 (below): Ford – score of two; hyperemia & edema.
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Figure 9 - Horse #9 (above): Blisstex – score of one; hyperemia.
Figure 10 - Horse #10 (below): Jill – score of zero.
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Figure 11 – Image Captured from Video of Horse #3 (above): This video segment
revealed petechial hemorrhage in Andy, a horse from the no infusion treatment group.

6. Discussion
In general, the irrigation and endoscopy procedures were well tolerated by the
mares involved in this study, and only mild and localized signs of tissue irritation were
observed. No sedatives were administered during irrigation. Five horses received
sedation for the endoscopy procedure, however; two of these horses were also involved in
dental procedures during the same time period and may not have needed sedation solely
for the endoscopy procedure.
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Andy (horse #3) was the only horse in the no infusion treatment group that
showed evidence of inflammation upon endoscopy. The still frame images showed
evidence of hyperemia and the uterus was given the score of one. This can be partially
explained because the initial endoscopy video collected for this mare did not record.
Two days later, this horse underwent a second endoscopy procedure to replace the data.
The presence of hyperemia therefore may be associated with cervical penetration. If this
is the case, horses infused with NAC or LRS may show hyperemia in response to
penetration and this indication of inflammation might not be in direct response to the
LRS or NAC solutions. Additionally, an area containing petechial hemorrhage was
discovered upon review of the video for Andy (see Figure 11). Video findings were not
evaluated in this study and Table 2 does not reflect this finding. This incidence of
petechial hemorrhage is caused by mechanical damage from the endoscope and cannot be
attributed to an infusion since this mare was in the no infusion treatment group.

Transudate and petechial hemorrhage were two greater degrees of tissue irritation
seen for the LRS treatment group. The petechial hemorrhage seen in the uterus of Dewey
(horse #5) could have resulted from the insemination pipette or the endoscope scraping
the uterine tissues as was similarly found in Andy (horse #3). Additionally, the reddishbrown fluid labeled as transudate found in Wicky (horse #6) was not sampled for testing
and can therefore not be identified with certainty. Both of these findings could be a result
from pre-existing uterine damage or mechanical damage as a result of this study, and may
not be directly caused by the LRS solution. Future studies should consider collecting
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initial endoscopic images before irrigation which may help distinguish the direct cause of
these two types of inflammatory responses.

There is a clear relationship between the cumulative uterine score and the
treatment group (see Table 3). Horses in the no infusion group showed no or limited
inflammation, and horses in the NAC treatment group showed less signs of tissue
irritation when compared to horses from the LRS treatment group. Since the 3.3% NAC
solution was made by diluting 20% acetylcysteine in Lactated Ringer’s Solution, these
results indicate that NAC has an anti-inflammatory effect. A few other recent studies
have similarly found that NAC is anti-inflammatory when compared to saline treatments
(Melkus et al., 2011; LaBlanc, 2010). LaBlanc (2010) states; “Data indicated that NAC
was not harmful to the endometrium and that it may counteract the irritating effect of
saline.”

Future studies should continue to evaluate the anti-inflammatory properties of
NAC through blinded, scientific studies. Additionally, varying concentrations of NAC
should be tested and other time intervals should be used to verify that NAC is only mildly
irritating to mucosal tissue. Testing in the uterus has provided many benefits to this
study, and although continuing studies should use this organ, tissue response to NAC
irrigations applied to the guttural pouch also need to be evaluated. It is recommended
that further studies evaluate the safety of infusing a 3.3% NAC solution into the guttural
pouch as well as test NAC for efficacy as a mucolytic agent in the treatment of horses
carrying S. equi after strangles outbreaks.
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It must be noted that the techniques of irrigation and endoscopy may limit the
practicality of infusing the guttural pouch with NAC as a treatment for strangles. These
techniques may not be easily adaptable to field work and may be better suited for use in
hospital settings. Irrigation of the guttural pouch requires the use on an endoscope, and
this equipment is too bulky and expensive to be used widely by practitioners in the field.

7. Conclusions and Implications
The results of this observational study show that intrauterine infusions of NAC
and LRS cause increased irritation to epithelial tissue when compared to horses from the
no infusion treatment group. Additionally, the uteri infused with NAC showed less
inflammatory response when compared to those infused with LRS indicating that NAC
could have anti-inflammatory affects on mucosal tissues. All inflammatory responses
were mild and localized to the uterus. Evidence from this study suggests that NAC does
have the potential to be a low-risk treatment option for the carrier state of strangles.
Further testing will be needed to verify the anti-inflammatory properties of NAC as well
as to evaluate the efficacy of cleansing the guttural pouch of horses involved in strangles
outbreaks with NAC.
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Appendix 1 – IACUC Approval
PROTOCOL NUMBER:

August 2010 version

UNIVERSITY OF MAINE
PROTOCOL REVIEW FORM
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE
GENERAL INSTRUCTIONS: The Institutional Animal Care and Use Committee (IACUC)
consists of scientists from several disciplines as well as non-scientists, members of the University
community, and persons who have no other affiliation with the University than as members of the
Committee. The protocol should therefore be described in terms understandable by an audience
of educated nonspecialists. Please return the completed protocol to the Institutional Animal
Care and Use Committee, c/o Office of the Vice President for Research, 114 Alumni Hall.
The form is due TWO weeks prior to a scheduled IACUC meeting. The meeting dates are
posted at: http://www.umaine.edu/research/research-compliance/institutional-animal-careand-use-committee-iacuc/meeting-schedule-and-protocol-due-dates/. Protocols received late
will be held until the next month’s meeting. Please call Gayle Jones at 1-1498 if you have
questions.
The Principal Investigator or Instructor must justify the ethical costs of using live animals by
demonstrating a reasonable expectation that such usage will contribute to the advancement of
knowledge which may eventually benefit humankind and/or animals. The Principal Investigator
or Instructor must further demonstrate that he or she has applied the concepts of "alternatives" in
designing the protocol. The term “alternatives” includes three components: replacement (using
organisms that are phylogenetically lower, cell cultures, tissues from slaughter or autopsy, or
nonanimal systems); reduction (in the number of animals used); and refinement (of design and
methods to reduce pain and stress to animals used as well as ensuring that the number of animals
used is optimal for the analysis proposed).
1.

Principal Investigator, Co-Investigator(s), or Instructor(s), with campus address, office
phone, and lab phone of PI (NOTE: The Principal Investigator or Instructor must be a
faculty member or professional staff):
PI: Robert Causey Associate Professor, Animal and Veterinary Sciences,
Hitchner Hall Tel: 581-2782
CI: Christine Kissinger (AVS Capstone/Honors student)
Title and number of course/Title of project:

Endoscopic evaluation of the response to intrauterine irrigation with 3.3 % N
Acetyl Cysteine
Project/Course Start Date: February 1, 2012
Number of years project is planned to continue: Three
(IACUC approval is granted for three years)
If this is a renewal application, please enter the exact project or course title and previous protocol
code. Be sure to identify any changes from the previously approved protocol.
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Funding agency for project, if applicable. Include title of proposal if different from this
protocol.
Maine Technology Institute/Maine Technology Asset Fund: Commercialization of
New Technologies for Animal Disease Surveillance

2.

Describe the (check appropriate category) __X__research, __X__teaching, or
____production objectives (not procedures) that involve use of animals. Explain these
objectives in non-technical language. Do not paste in sections of grant proposals.
To detect and describe by endoscopic examination of the equine uterus the
occurrence of irritation caused by intrauterine infusion of N - acetyl cysteine.

3.

Describe how this use of animals contributes to the advancement of knowledge, which
may eventually benefit humankind and/or animals.

Infertility in the mare is a serious cause of economic loss to horse owners. In
addition, infertile mares quickly lose their value and run the risk of being sold, discarded or
abandoned. Methods to treat infertility in mares therefore benefit both horse owners and
maintain the value of breeding stock.
Recently 3.3% N-acetyl cysteine (NAC) in lactated ringers solution (LRS) has shown
promise as an anti-inflammatory and mucolytic agent when infused in the equine uterus,
and has been associated with improved conception rates. In contrast, 20 % N-acetyl cysteine
administered in the guttural pouch has been associated with mucosal irritation as detected
by endoscopy. We therefore wish to determine if N-acetyl cysteine, used at 3.3% strength,
shows signs of irritation in the uterus, which may be a contraindication for its use.
Because this is the first time an endoscopic evaluation of the uterus has been
performed post NAC infusion, it is necessary to classify this as a pilot-study in which
variation to infusion may be estimated, preparatory to possible follow-up studies.
4.

Identify the animals to be used (genus and species) and number (for the entire project).

Equus caballus 12 total, 4 treatment animals (3.3% NAC in LRS), 4 animals
infused with LRS only and 4 uninfused controls.
5.

State the rationale for use of this/these species. Address the issue of replacement by
explaining why educational or research objectives cannot be met by the use of
phylogenetically lower organisms, cell or tissue cultures, or non-animal systems. (Please
note: the IACUC does not consider "hands-on experience" to be in and of itself an
adequate educational objective, unless the course serves students whose anticipated
educational and professional futures will require the skills imparted through such handson experience. If that is true in this instance, please describe the student population that
typically enrolls in the course.)

There is no substitute for the live horse in this study because the horse tends to be
idiosyncratic in its response to uterine infusions. Consequently there is no in-vitro or
computerized model which we can use to confidently predict response to infusion with
NAC, nor could results in a phylogenetically lower organism be extended with confidence to
the horse.
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6.

Justify the number of animals:
a.

Explain how the number of animals required fits your experimental design or
teaching or production/breeding objectives.

We are planning a descriptive pilot - study involving 4 animals treated with
NAC, 4 treated with LRS, and 4 un-infused animals. Assessment of acute endometrial
irritation is based on visual inspection of endometrial hyperemia (redness due to increased
arterial blood flow), hemorrhage, edema and exudate. The internal medicine literature
describing irritation of the equine guttural pouch infused with 20 % NAC raises sufficient
questions about the potential irritation caused by NAC to justify this study.
b.

Give the rationale for the number in terms of the statistical methods to be used.
Address the issue of reduction by explaining why the proposed number is
sufficient, but not excessive. (A simple statement that the number proposed is
required for statistical significance is not an adequate response.) See How to do
a Power Analysis. For research in which the number of animals is limited not by
statistical power, but by the number of animals that can be captured, maintained,
or sampled, a power analysis will provide an indication of the statistical power of
the proposed tests based on the variance measured by the researcher, or others, in
previous studies. For studies not amenable to a Power Analysis (e.g., no data on
variability available, only descriptive data available), provide a justification for
why a power analysis is not appropriate for your project.

The number requested is adequate because this is a pilot study and no
formal statistical analysis is proposed.
7.

PROCEDURES

The Committee does not wish to receive copies of research proposals or laboratory manuals. The
Principal Investigator or Instructor is asked to address succinctly the following questions,
as applicable. Special care should be taken to justify any procedures generally
discouraged by the University's code of ethics and policy.
a.

Major categories of procedures. Please check the appropriate box for each
category.
Any “yes” responses must be described in sections b. (nonsurgical
procedures) and/or c. (surgical procedures) that follow. Please attach the
category headings (from 1-16 below) to the description of procedures in
sections 7b and c.

Yes

No
X
X
X

1.
2.
3.

X

4.
5.

X

collection or capture
kill and harvest tissue
immunization for antibody production: describe antigen, adjuvant used,
route of immunization, method of obtaining blood
physiologic measurements
dietary manipulations
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X

6.
X
X
X
X
X

7.
8.
9.
10.
11.

X
X
X

12.
13.
14.

X

15.

X

16.

b.

pharmacology/toxicology: material used, route of administration, etc.
3.3 % NAC in lactated ringers solution administered intrauterinely
behavior studies
environmental stress, e.g., temperature, restraint, forced exercise
irradiation: type, facility to be used
hazardous materials, e.g., carcinogens, radioactive materials
biohazardous or infectious agents (use of Class 2 or higher agents
requires the approval of the University's Biosafety Committee)
experimental trauma
nonsurvival surgical procedure
survival surgical procedure (animal is allowed to recover for any length
of time)
multiple major operative procedures from which animal is allowed to
recover
other, specify:
Uterine infusion and uterine endoscopy

Nonsurgical Procedures:
Describe all nonsurgical manipulations or procedures, if any, involving the
animal, e.g., drug administration, blood collection, diet change, collection,
capture. Specify the drug(s), dose, route of administration, or other methods
used. Specify duration of procedures. If an adjuvant will be used, state the
number of injection sites per dosage and the number of doses.
Using aseptic technique a sterile solution of 30 mL of a 20% solution of NAC
combined with 150 mL of sterile lactated ringers solution will be introduced
into the uterus of 4 mares. An additional 4 mares will receive 180 mL
lactated ringers solution only. Twenty four hours following infusion the
perineal region will be aseptically prepared and a chemically sterilized, 9mm
diameter flexible endoscope introduced per vaginam into the uterus, and the
endometrium visualized and recorded digitally. Following endoscopy of all
mares images of the uteri will be examined as a group and endometria
indicating irritation will be identified. Assessment of irritation will be made
by an individual (the PI) blinded to whether the horse received an infusion
of NAC or saline.
Uterine endoscopy and uterine infusion are routine procedures in the mare
which may be performed without sedation. However, sedation will be
administered if the mare appears anxious (detomidine hydrochloride - 5 or
10 mg IV). This is a routinely used method of sedation well tolerated by
horses. Sedated horses will be allowed time to regain full consciousness in
their stall, hay and water having been removed to prevent choking hazards,
and then turned back out onto pasture when fully alert.
Examinations will not exceed 10 minutes, and will be curtailed if evidence of
irriation associated with endoscopy is detected.

Will the animals be killed? If so, what method of euthanasia will be used?
(Include dosages if applicable.) See the 2007 Report of the AVMA Panel on
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Euthanasia for assistance
(http://www.avma.org/issues/animal_welfare/euthanasia.pdf). If not, what final
disposition of the animals is planned?
NO. Animals will remain part of the UMaine Standardbred herd at the
Witter Center.
If euthanasia becomes necessary, due to unplanned injury or illness to the
animal(s), how will it be accomplished (include dosages if applicable)? See the
2007 Report of the AVMA Panel on Euthanasia for assistance
(http://www.avma.org/issues/animal_welfare/euthanasia.pdf). NOTE: question
must be answered.
If necessary, euthanasia will be performed by rapid intravenous
administration of 100 ml of 390 mg/mL Sodium pentobarbital with 50
mg/mL sodium phenytoin (euthanasia solution) by one of the attending
veterinarians from Foxcroft Veterinary Services, Dover-Foxcroft, ME.

c.

Surgical Procedures:
Describe briefly any surgical procedures. Describe the anaesthetic method,
including all drugs, dosages, routes of administration, and supplementation
schedules. Describe the postsurgical monitoring and care procedures, including
what response(s) you will look for to indicate recovery, and the method of
euthanasia (if it becomes necessary due to unplanned injury or illness).
N/A
Is animal allowed to recover for any length of time? Yes/No If yes, how long
will animal survive surgery?
N/A
If there is potential for discomfort or pain as a result of the procedures, describe
their nature and duration. Explain what will be done to relieve them, including
drugs and dosages, nursing care, mechanical devices, etc.
N/A

d.

Search for Alternatives: If the proposed procedures cause more than momentary
or slight pain or distress to the animal(s), federal regulations require that you
search for alternatives. The PI must provide a written narrative description (see
NOTE below) of the sources used to determine that less painful alternatives are
not available. To fulfill this requirement, bibliographical searches may be
performed through the Animal Welfare Information Center (AWIC) of the
National Agriculture Library
(http://awic.nal.usda.gov/nal_display/index.php?info_center=3&tax_level=1&tax
_subject=184).
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Will the proposed procedures cause more than momentary or slight pain or distress to the
animal(s)?
X

No. (Examples of procedures for which this response is appropriate include
observation of behavior under conditions of little or no distress, dietary
manipulations, and injections or blood sampling by qualified personnel.)

Yes. (Examples of procedures for which this response is appropriate
include survival surgery, nonsurvival surgery, electrofishing, and
procedures producing pain or distress unrelieved by analgesics such as
toxicity studies, microbial virulence testing, radiation sickness, and
research on stress, shock, or pain.) The required narrative is attached.
NOTE: When preparing the narrative, the instructions in the USDA
policy MUST be followed. For a description of this policy, see:
http://www.aphis.usda.gov/animal_welfare/downloads/policy/policy1
2.pdf.
NOTE: When proposed procedures will cause more than momentary or
slight pain or distress to animal(s), a consultation with the attending
veterinarian must occur in the planning stages of those procedures
prior to submitting this protocol for review. Please email Dr. James
Weber, james.weber@umit.maine.edu, with a description of the
proposed procedures and your approach to minimizing pain/distress.
8.

Animal Sources and Housing

a.

Please indicate source of animals. Note: The IACUC will approve animal purchases
from a licensed pet store provided the researcher/instructor informs the pet store
(in writing) that the purchased animals will be used for research/teaching.
UMaine Standardbred Herd

b.

If the animals are caught in the wild:
N/A
Where and how will the animals be trapped?
N/A
How often will the traps be checked?
N/A
What other steps will be taken to protect the animals from exposure or other danger?
N/A
Indicate if Federal/State permits are required and whether they have been obtained.
N/A
If the animals will be brought to the campus, what precautions will be taken to prevent
zoonotic diseases?
N/A
Please include your plans for removal of traps or barriers (e.g., pitfall traps).
N/A
c.

Where will the animals be housed? Describe the housing (See the Guide for the
Care and Use of Lab Animals
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(http://www.nap.edu/readingroom/books/labrats/) pages 22-36) for
information on Physical Environment, including space requirements. If your
housing will not meet the Guide requirements, include a request for an exception
to the Guide. If your animals are not listed in the Guide, housing should meet the
recommendations of the appropriate guidelines for the proposed species. Include
dimensions of cage, tank, etc.
J F Witter Teaching and Research Center
d.

Identify the room or facility in which the procedures will be conducted.
Animal Handling Room

9.

List all person(s) (including PI) who will handle animals (e.g., carry out the procedure(s),
animal care, etc.) or provide training of personnel. For each person named below,
describe his/her experience in performing proposed procedures; if none, explain how
training will be obtained.

Name/Title/Experience
Robert Causey DVM, PhD, Diplomate American College of Theriogenologists. Has
experience of uterine infusion and endoscopy in teaching, clinical and research settings.
Christine Kissinger: Senior student. This project is her capstone/honors thesis and all
her work will be carried out under the supervision of the PI.

10.

If animals will be housed, please list the name, phone number, and email of the person
who should be contacted to accompany the IACUC during facility inspections:

Robert Causey 581-2782 email on first class
11.

Have all personnel named above been certified by the IACUC for Responsible Care and Use
of Animals?
X Yes
No A web-based tutorial for this certification is available at:
http://umaine.edu/research/research-compliance/institutional-animal-care-and-use-committeeiacuc/web-based-training/. (Note: protocols will not be processed until all personnel have
been certified.)
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12.

Risk Assessment (risks to researchers):
In compliance with our Public Health Service Animal Welfare Assurance, we have
implemented an Occupational Health/Medical Surveillance Program. The first step will
be for investigators to identify potential hazards with tasks involved with the study, so the
IACUC veterinarian and Safety and Environmental Management (SEM) can assess the
risks to determine if further information will be required from everyone named in the
protocol (i.e., a health questionnaire).
Please complete the following for your proposed protocol.

a)
Provide a brief description of the protocol (cut and paste response from question
2 of the protocol). (NOTE: Only this page, not the whole protocol, goes to SEM and the
Occupational Health Physician, thus the request for duplication of the answer to question
2.)
To detect and describe by endoscopic examination of the equine uterus the
occurrence of irritation caused by intrauterine infusion of N- acetyl cysteine.
b)

List the tasks required.
1. Uterine Endoscopy
2. Uterine infusion
3.

c)

For each of the tasks described in b) above, list the associated hazards.
1. Horse resisting procedures leading to injury of people
2.
3.
etc.

d)

For each of the hazards described in c) above list how the hazards will be
managed.
1. Chemical Restraint (sedation) if necessary
2. Physical Restraint (stocks)
3. Animal handlers trained by and under supervision of PI.

NOTE: In evaluating this risk assessment statement, we will be looking for animal care tasks that
increase the risk of illness (such as a zoonotic disease), physical injury (such as animal bites),
and/or allergic reactions to those handling the animals.
After this risk assessment is reviewed, everyone named in the protocol may be required to
complete a health questionnaire. The health questionnaire may require review by the
Occupational Health Physician. If so, there is a charge for this review, and you will be
required to provide an account number. (Currently the charge is $45; we do not know the
cost of a physical exam if warranted after review of the questionnaire, but this page will be
updated when that information is known.)
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If you have any questions regarding the completion of this page, please contact James
Patrick, Safety and Environmental Management, 1-4055.
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